Sept. 15 Patient Summit Spotlights Cancer Immunotherapy
Columbia University Irving Medical Center (CUIMC) is set to co-host the Cancer Research Institute’s (CRI) Immunotherapy Patient Summit on Sept. 15, 2018. The half-day event, which is free and open to the public, will provide patients, caregivers and advocates an opportunity to learn about cancer immunotherapy directly from patients, who have been treated with immunotherapy, and from the medical experts and researchers firsthand who are focusing on the new treatment approach.
Immunotherapy is a type of cancer treatment that uses elements of the body’s immune system to fight cancer. At Columbia, several programs and clinical trials are in place to learn more about the benefits of immunotherapy in treating cancer. At the Immunotherapy Patient Summit, leading oncologists with expertise in general immunotherapy, melanoma, blood cancer and gastrointestinal cancers, including NewYork-Presbyterian/CUIMC’s Charles Drake, MD, PhD and Gulam Manji, MD, PhD, will participate in panel discussions and moderated Q+As. Attendees also will learn about clinical trials and have the opportunity to book a one-on-one appointment with a clinical trial navigator to find out about cancer clinical trials and how to access them.
Dr. Manji, for one, will discuss what role immunotherapy is playing in gastrointestinal malignancies and where it appears to be challenging. “Immunotherapy is revolutionizing how we treat cancer ... New clinical trials are changing the treatment landscape and it is critical that both patients and providers keep up with new treatment and treatment combinations with immunotherapy and ongoing promising clinical trials," he says. "For gastrointestinal cancers, immunotherapy is emerging to play a central role in liver cancer where few options existed only a few years ago.”
The summit will take place at the CUIMC campus in the Roy and Diana Vagelos Education Center. For further details and to register, visit the CRI Event Page.